|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5665900||1407776||2017||3 صفحه PDF||سفارش دهید||دانلود کنید|
- Previous studies have suggested KPC-producing Enterobacteriaceae may have intermediate susceptibility to tetracyclines
- In vitro activity of minocycline was examined for 103 KPC-producing Enterobacteriaceae
- Approximately half had susceptible (26%) or intermediate (26%) minocycline MICs
- For a subset (nÂ =Â 35), susceptibility was highest to tigecycline followed by minocycline and then doxycycline
We examined the in vitro activity of minocycline against 103 Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae isolates and found approximately half had susceptible (26%) or intermediate (26%) MICs. For a subset of 35 isolates, susceptibility was highest to tigecycline (71% FDA vs. 20% EUCAST) followed by minocycline (14%) and then doxycycline (6%).
Journal: Diagnostic Microbiology and Infectious Disease - Volume 88, Issue 4, August 2017, Pages 365-367